- Tytuł:
-
Owrzodzenia podudzi i trudno gojące się rany
Venous ulcers and difficult-to-heal wounds - Autorzy:
- Citko, Anna
- Powiązania:
- https://bibliotekanauki.pl/articles/2138938.pdf
- Data publikacji:
- 2022-06-01
- Wydawca:
- Wydawnictwo Naukowe Medyk sp. z o.o.
- Tematy:
-
venous ulcers
difficult-to-heal wounds
TIME strategy
TIAB molecules
owrzodzenia podudzi
rany trudno gojące się
strategia TIME
molekuła TIAB - Opis:
- In Poland, the most common types of difficult-to-heal wounds include: venous ulcers, pressure ulcers, ulcers associated with the diabetic foot syndrome, ischemic (arterial) ulcers and neoplastic wounds. In the local management of chronic wounds, the TIME strategy should be used (T – tissue and debridement – tissue preparation; I – infection and inflammation control – infection and inflammation control; M – moisture balance – wound moisture balance; E – edges – wound edges – no healing progress or undermining the edge of the wound and epidermization stimulation). The TIME strategy pays particular attention to reducing the risk of wound infection. The treatment of TIAB molecules [titanum argentum-benzoicum] in the treatment of chronic wound infection may be among the measures taken to reduce the risk of chronic wound infection. The introduction of nanotechnology and the combination of ionic silver nanoparticles with titanium dioxide by covalent bonds in the TIAB complex, revolutionized the effect of silver, many times increasing its antibacterial and antifungal properties, and removing its toxic effect by preventing accumulation in tissues. The precipitation of metallic silver from ionic compounds resulted in the loss of activity of the preparations and, with prolonged use, could lead to tissue damage. The patented form of TIAB silver on the titanium core has only an ionic / stable form of silver which is not reduced by exposure to light, as well as organic and inorganic compounds. TIAB silver is available in the form of a spray and cream, and has a proven effect on pressure ulcers and ulcers that heal difficult to heal. At the same time, it does not show any allergy to silver with prolonged use. The use of the TIAB molecule in the treatment of ulcers with symptoms of colonization was presented at the congress of the European Wound Treatment Society in 2012 in Vienna as a new and highly effective solution.
- Źródło:
-
Lek w Polsce; 2022, 373, 06; 8-14
2353-8597 - Pojawia się w:
- Lek w Polsce
- Dostawca treści:
- Biblioteka Nauki
Artykuł